TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 119 filers reported holding TANGO THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.38 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28,267,429 | +15.6% | 3,294,572 | +6.9% | 0.00% | – |
| Q1 2024 | $24,462,228 | -17.1% | 3,080,885 | +3.4% | 0.00% | -100.0% |
| Q4 2023 | $29,494,199 | -10.9% | 2,979,212 | +1.3% | 0.00% | 0.0% |
| Q3 2023 | $33,102,632 | +263.6% | 2,939,843 | +7.2% | 0.00% | – |
| Q2 2023 | $9,104,168 | -16.2% | 2,742,219 | -0.3% | 0.00% | – |
| Q1 2023 | $10,862,193 | -44.8% | 2,749,922 | +1.3% | 0.00% | -100.0% |
| Q4 2022 | $19,682,387 | +108.8% | 2,714,812 | +4.3% | 0.00% | – |
| Q3 2022 | $9,426,000 | -30.9% | 2,603,744 | -13.6% | 0.00% | – |
| Q2 2022 | $13,644,000 | -33.7% | 3,011,918 | +11.0% | 0.00% | – |
| Q1 2022 | $20,571,000 | +30.0% | 2,713,963 | +87.6% | 0.00% | – |
| Q4 2021 | $15,829,000 | -11.6% | 1,446,765 | +4.5% | 0.00% | – |
| Q3 2021 | $17,906,000 | – | 1,384,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,201,475 | $164,748,656 | 81.48% |
| Mass General Brigham, Inc | 354,192 | $3,038,967 | 14.80% |
| Nextech Invest Ltd. | 5,533,980 | $47,481,548 | 7.99% |
| Boxer Capital, LLC | 8,198,642 | $70,344,348 | 3.70% |
| EcoR1 Capital, LLC | 13,330,736 | $114,377,715 | 3.50% |
| Braslyn Ltd. | 26,961 | $231,325 | 2.77% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $24,819,049 | 2.72% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 115,571 | $991,599 | 1.25% |
| Samsara BioCapital, LLC | 630,000 | $5,405,400 | 1.13% |
| Southpoint Capital Advisors LP | 5,276,699 | $45,274,077 | 1.13% |